RHI vs SABSW · P/E 21, rev $5.38B vs P/E 0.0
Robert Half International Inc (RHI) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
SABSW does not have a complete income-statement cache yet.
RHI currently screens at market cap $4.38B and trailing P/E 21.4. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the RHI and SABSW stock pages for the full models.
Not investment advice.